Celeras Dx’ patient monitoring delivers speedy status reports on biomarkers which are associated with clinical decisions to be made during treatment of serious infection - especially sepsis. The tests have been conceived for the periodic testing of patients in such a manner that the minimum use of samples is involved and a simple and rapid analysis is available. The aim is to deliver a “picture” of the inflammation and organ status which is as complete as possible and which quickly indicates any deterioration in the condition of the patient.

The sample is pipetted into the hybcell (=cartridge). The sample dissolves a reaction mix lyophilised within the cartridge. The hybcells are transferred to the hyborg – the fully automatic device. The measured values are interpreted by the software and presented within the measurement range as quantitative results in a tabulated report.

xA panel (Research Use Only):

• CRP - acute-phase protein-marker for inflammation.
• Cystatin C - protease inhibitor indicating kidney failure.
• Myoglobin - elevated levels indicate damages of heart muscle.
• NGAL - elevated levels indicate damages of kidney.
• PCT - is elevated during bacterial infections.
• Plasminogen and D-Dimer - are biomarkers for the status of coagulation.
• Serumamyloid A (SAA) - is an acute-phase protein-marker elevated during bacterial- and viral infections.
• Tachykinin (Substance P) - is a neurotransmitter and a marker for a progressed stage of sepsis.